DR.REDDY'S LABORATORIES LTD. Share Price Chart | DRREDDY.BO

STI

0.30%

Dr. Reddy's Laboratories Ltd. (DRREDDY.BO)

-BSE

2,019.40 28.15(1.37%) 18:15 SGT

Add to Portfolio

To view the interactive charts download and install the latest version of Flash Player by clicking on the image

or view the Basic charts here

Dr. Reddy's Laboratories Ltd. (DRREDDY.BO)

-BSE

Prev Close:	2,047.55
Open:	2,052.00
Bid:	2,019.40
Ask:	2,019.40
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	2,012.00 - 2,066.30
52wk Range:	1,528.00 - 2,150.90
Volume:	20,904
Avg Vol (3m):	16,020
Market Cap:	342.98B
P/E (ttm):	20.51
EPS (ttm):	98.44
Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

Asia's Best Analyst: Health Care at The Wall Street Journal Sun, 12 May
Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection at noodls Thu, 4 Apr
Dr. Reddy’s appoints GV Prasad as Chairman and Satish Reddy as Vice-Chairman of the Company at noodls Tue, 2 Apr
Dr. Reddy’s announces the launch of Zenatane™ (Isotretinoin Capsules USP) at noodls Fri, 29 Mar
Dr. Reddy’s and Nordion Inc. (formerly MDS Inc.) settle claims at noodls Mon, 25 Mar
[$$] Dr Reddy's Laboratories Founder Anji Reddy Dies at The Wall Street Journal Sat, 16 Mar
Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection at noodls Tue, 5 Mar
Dr. Reddy’s Q3 & 9 months FY13 Financial Results: Q3 FY13 Revenues at Rs.28.7 billion (YoY growth of 23%); 9 months FY13 Revenues at Rs.82.9 billion (YoY growth of 26%) at noodls Thu, 14 Feb
Dr. Reddy's to release Q3 FY13 results on February 14, 2013 Earnings call slated for February 14, 6.30 PM IST / 8.00 AM EST* at noodls Mon, 11 Feb
Dr. Reddy’s announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets) at noodls Fri, 1 Feb

More Headlines for DRREDDY.BO

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ. International historical chart data, daily updates, fund analyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon. Copyright © 2010 Briefing.com. All rights reserved.

Yahoo! Singapore Finance

Search for share prices

More On DRREDDY.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Dr. Reddy's Laboratories Ltd. (DRREDDY.BO)

Dr. Reddy's Laboratories Ltd. (DRREDDY.BO)

Headlines